Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy:
Status:
Not yet recruiting
Trial end date:
2023-05-15
Target enrollment:
Participant gender:
Summary
The purpose of this randomized trial is to investigate the effect of the complete removal of
pharmacological treatment in patients responding to cardiac resynchronization therapy with
recuperated LVEF in terms of imaging parameters (changes in LVEF and LV volume), as well as,
clinical parameters that translate into worsening of heart failure.
Phase:
Phase 4
Details
Lead Sponsor:
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia